Everest Organics Limited (BOM:524790)
India · Delayed Price · Currency is INR 276.35
-20.35 (-6.86%)
At close: Mar 4, 2026
Everest Organics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 1,883 | 1,595 | 1,972 | 1,830 | 2,000 | 1,816 |
Other Revenue | 10.91 | 4.75 | 7.83 | 8.21 | 15.48 | 5.09 |
| 1,894 | 1,600 | 1,980 | 1,839 | 2,016 | 1,821 | |
Revenue Growth (YoY) | 10.25% | -19.23% | 7.70% | -8.79% | 10.72% | 8.43% |
Cost of Revenue | 1,248 | 1,025 | 1,293 | 1,263 | 1,410 | 1,134 |
Gross Profit | 646.64 | 574.59 | 686.9 | 575.39 | 606.16 | 686.65 |
Selling, General & Admin | 177.62 | 181.77 | 207.86 | 174.72 | 172.57 | 156.64 |
Other Operating Expenses | 286.04 | 309.26 | 361.36 | 382.75 | 352.74 | 296.01 |
Operating Expenses | 531.36 | 557.24 | 627.17 | 602.21 | 563.28 | 486.39 |
Operating Income | 115.29 | 17.35 | 59.74 | -26.82 | 42.88 | 200.26 |
Interest Expense | -41.57 | -44.31 | -48.43 | -29.39 | -26.16 | -20.11 |
Interest & Investment Income | 2.57 | 2.57 | 0.97 | 0.35 | 0.54 | 1.09 |
Currency Exchange Gain (Loss) | -0.45 | -0.45 | 0.06 | 5.91 | 4.99 | 3.71 |
Other Non Operating Income (Expenses) | -7.6 | -7.59 | -6.24 | 0.33 | -4.85 | -12.21 |
EBT Excluding Unusual Items | 68.24 | -32.43 | 6.1 | -49.62 | 17.39 | 172.74 |
Gain (Loss) on Sale of Assets | - | - | - | 0.52 | - | - |
Pretax Income | 68.24 | -32.43 | 6.1 | 0.9 | 17.39 | 172.74 |
Income Tax Expense | 9.94 | -19.52 | 4.71 | 2.72 | 5.96 | 35.59 |
Net Income | 58.3 | -12.9 | 1.39 | -1.82 | 11.44 | 137.15 |
Net Income to Common | 58.3 | -12.9 | 1.39 | -1.82 | 11.44 | 137.15 |
Net Income Growth | - | - | - | - | -91.66% | 25.86% |
Shares Outstanding (Basic) | 10 | 10 | 8 | 8 | 8 | 8 |
Shares Outstanding (Diluted) | 10 | 10 | 8 | 8 | 8 | 8 |
Shares Change (YoY) | 19.18% | 18.59% | 3.36% | -0.95% | -0.05% | 0.02% |
EPS (Basic) | 6.05 | -1.33 | 0.17 | -0.23 | 1.43 | 17.14 |
EPS (Diluted) | 6.05 | -1.33 | 0.17 | -0.23 | 1.43 | 17.14 |
EPS Growth | - | - | - | - | -91.66% | 25.84% |
Free Cash Flow | - | -89.54 | 30 | 48.85 | -34.17 | 66.84 |
Free Cash Flow Per Share | - | -9.22 | 3.66 | 6.17 | -4.27 | 8.35 |
Dividend Per Share | - | - | - | - | 0.500 | 1.500 |
Dividend Growth | - | - | - | - | -66.67% | 50.00% |
Gross Margin | 34.13% | 35.92% | 34.69% | 31.29% | 30.07% | 37.71% |
Operating Margin | 6.09% | 1.08% | 3.02% | -1.46% | 2.13% | 11.00% |
Profit Margin | 3.08% | -0.81% | 0.07% | -0.10% | 0.57% | 7.53% |
Free Cash Flow Margin | - | -5.60% | 1.52% | 2.66% | -1.70% | 3.67% |
EBITDA | 176.16 | 76.98 | 117.69 | 17.92 | 80.85 | 234.01 |
EBITDA Margin | 9.30% | 4.81% | 5.94% | 0.97% | 4.01% | 12.85% |
D&A For EBITDA | 60.87 | 59.62 | 57.96 | 44.74 | 37.97 | 33.75 |
EBIT | 115.29 | 17.35 | 59.74 | -26.82 | 42.88 | 200.26 |
EBIT Margin | 6.09% | 1.08% | 3.02% | -1.46% | 2.13% | 11.00% |
Effective Tax Rate | 14.56% | - | 77.20% | 302.67% | 34.24% | 20.60% |
Revenue as Reported | 1,896 | 1,602 | 1,981 | 1,900 | 2,023 | 1,826 |
Advertising Expenses | - | 14.25 | 14.39 | 11.66 | 9.24 | 3.95 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.